Stockscreener 앱 받기
7.31
1.62%
-0.12
시장 영업 전:
7.48
0.17
+2.33%
전일 마감가:
$7.43
열려 있는:
$7.43
하루 거래량:
63,168
Relative Volume:
0.91
시가총액:
$169.91M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.94%
1개월 성능:
+13.86%
6개월 성능:
-19.76%
1년 성능:
-16.65%
1일 변동 폭
$7.23
$7.50
1주일 범위
$6.68
$7.787
52주 변동 폭
$5.47
$11.99
Actuate Therapeutics Inc Stock (ACTU) Company Profile
명칭
Actuate Therapeutics Inc
전화
847-986-4190
주소
1751 RIVER RUN, FORT WORTH
ACTU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACTU
Actuate Therapeutics Inc
|
7.31 | 172.70M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Actuate Therapeutics Inc Stock (ACTU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-26 | 개시 | B. Riley Securities | Buy |
| 2025-04-22 | 개시 | Craig Hallum | Buy |
| 2025-03-17 | 개시 | H.C. Wainwright | Buy |
Actuate Therapeutics Inc 주식(ACTU)의 최신 뉴스
Will Actuate Therapeutics Inc. stock see PE expansionInsider Selling & Daily Chart Pattern Signal Reports - Newser
Why Actuate Therapeutics Inc. stock is a must watch in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser
Actuate Therapeutics enters $100 million at-the-market sales agreement - Investing.com
Actuate Therapeutics Signs $100M Sales Agreement - TipRanks
Actuate Therapeutics Inc enters at the market issuance sales agreement with B. Riley and Craig-HallumSEC filing - marketscreener.com
How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06% - Zacks Investment Research
Why Actuate Therapeutics Inc. stock is recommended by analystsJuly 2025 Analyst Calls & Verified Technical Trade Signals - BỘ NỘI VỤ
What risks investors should watch in Actuate Therapeutics Inc. stockOptions Play & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Actuate Therapeutics, Inc.'s (NASDAQ:ACTU) market cap surged US$24m last week, private equity firms who have a lot riding on the company were rewarded - simplywall.st
BIOS Capital Management LP Buys 71,428 Shares of Actuate Therapeutics, Inc. $ACTU - Defense World
What analysts say about Actuate Therapeutics Inc stockTrade Execution Strategies & Daily Tips From Top Market Analysts - earlytimes.in
Will Upside Catalysts Materialize for Prime Industries Limited in YEARHigh Frequency Trading Trends & Free Unlock Rapid Growth Potential - earlytimes.in
HC Wainwright Has Bullish Estimate for ACTU FY2025 Earnings - Defense World
Why Actuate Therapeutics Inc. stock is in analyst buy zoneEarnings Trend Report & Verified Entry Point Signals - newser.com
Actuate Therapeutics: Strategic Advancements and Financial Outlook Drive Buy Rating - TipRanks
HC Wainwright & Co. Reiterates Actuate Therapeutics (ACTU) Buy Recommendation - Nasdaq
How Actuate Therapeutics Inc. stock compares to market leadersEarnings Overview Report & Expert Approved Momentum Ideas - newser.com
Using R and stats models for Actuate Therapeutics Inc. forecastingRate Hike & Fast Gaining Stock Reports - newser.com
Strategies to average down on Actuate Therapeutics Inc.Quarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
How Actuate Therapeutics Inc. stock benefits from tech adoptionTrade Volume Summary & Long-Term Growth Plans - newser.com
Advanced analytics toolkit walkthrough for Actuate Therapeutics Inc.July 2025 Short Interest & Weekly Return Optimization Alerts - newser.com
Is it time to cut losses on Actuate Therapeutics Inc.July 2025 Update & High Yield Stock Recommendations - newser.com
Here's Why We're Watching Actuate Therapeutics' (NASDAQ:ACTU) Cash Burn Situation - Yahoo Finance
What indicators show strength in Actuate Therapeutics Inc.July 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Actuate Therapeutics (NASDAQ:ACTU) Stock Price Up 0.5% on Better-Than-Expected Earnings - Defense World
Analysts Offer Insights on Healthcare Companies: Vicarious Surgical (RBOT) and Intensity Therapeutics, Inc. (INTS) - The Globe and Mail
Actuate Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Analysts Offer Insights on Healthcare Companies: Tyra Bioscience (TYRA), Janux Therapeutics Inc (JANX) and Eledon Pharmaceuticals (ELDN) - The Globe and Mail
What’s next for Actuate Therapeutics Inc. stock priceJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Real time scanner hits for Actuate Therapeutics Inc. explained2025 Sector Review & Precise Swing Trade Alerts - newser.com
Is Actuate Therapeutics Inc. building a consolidation base2025 Trading Recap & AI Forecast for Swing Trade Picks - newser.com
Myelofibrosis Market is Expected to Flourish in 7MM, Expanding - openPR.com
Actuate Therapeutics Inc (ACTU) 재무 분석
Actuate Therapeutics Inc (ACTU)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):